Author:
Wong Pancras C.,Crain Earl J.,Watson Carol A.,Wexler Ruth R.,Lam Patrick Y. S.,Quan Mimi L.,Knabb Robert M.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Hematology
Reference26 articles.
1. Quan ML, Wexler RR (2001) The design and synthesis of noncovalent factor Xa inhibitors. Curr Topics Med Chem 1:137–149
2. Pinto DJ, Orwat MJ, Wang S et al (2001) Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2′-(methylsulfonyl)-[1,1′-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa. J Med Chem 44:566–178
3. Wong PC, Pinto DJ, Knabb RM (2002) Nonpeptide factor Xa inhibitors: DPC423, a highly potent and orally bioavailable pyrazole antithrombotic agent. Cardiovasc Drug Rev 20:137–152
4. Quan ML, Lam PY, Han Q et al (2005) Discovery of 1-(3′-aminobenzisoxazol-5′-yl)-3-trifluoromethyl-N-[2-fluoro-4- [(2′-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide hydrochloride (razaxaban), a highly potent, selective, and orally bioavailable factor Xa inhibitor. J Med Chem 48:1729–1744
5. Wong PC, Crain EJ, Knabb RM et al (2000) Nonpeptide factor Xa inhibitors: II. antithrombotic evaluation in a rabbit model of electrically induced carotid artery thrombosis. J Pharmacol Exp Ther 295:212–218
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献